Back
Compugen Ltd. 10K Form
Sell
31
CGEN
Compugen Ltd.
Last Price:
$1.60
Seasonality Move:
24.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CGEN News And Ratings
See the #1 stock for the next 7 days that we like better than CGEN
CGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $27.9M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.47 |
| Price / Book: | 3.44 |
Profitability
| EPS (TTM): | -0.29920 |
|---|---|
| Net Income (TTM): | $-27.6M |
| Gross Margin: | $19.9M |
| Return on Equity: | -51.8% |
| Return on Assets: | -24.73% |
Compugen Ltd. Earnings Forecast
Key Compugen Ltd. Financial Ratios
-
The Gross Profit Margin over the past 26 years for CGEN is 71.54%.
-
The Selling, General & Administrative Expenses for CGEN have been equal to 35.94% of Gross Profit Margin.
-
The Research & Development expenses have been 89.04% of Revenue.
-
The Net Earning history of CGEN is -51.07% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 13 years.
Compugen Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CGEN |
| CUSIP: | M25722 |
| Website: | cgen.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 4.38 |
| Quick Ratio: | 4.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CGEN Technical Analysis vs Fundamental Analysis
Sell
31
Compugen Ltd. (CGEN)
is a Sell
Is Compugen Ltd. a Buy or a Sell?
-
Compugen Ltd. stock is rated a SellThe current Compugen Ltd. [CGEN] share price is $1.61. The Score for CGEN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.